266 related articles for article (PubMed ID: 31105886)
1. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer.
Yang H; Zhong JT; Zhou SH; Han HM
Oncotarget; 2019 Apr; 10(32):3066-3083. PubMed ID: 31105886
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
[TBL] [Abstract][Full Text] [Related]
3. GLUT and HK: Two primary and essential key players in tumor glycolysis.
Yadav D; Yadav A; Bhattacharya S; Dagar A; Kumar V; Rani R
Semin Cancer Biol; 2024 May; 100():17-27. PubMed ID: 38494080
[TBL] [Abstract][Full Text] [Related]
4. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Park SG; Lee JH; Lee WA; Han KM
Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
[TBL] [Abstract][Full Text] [Related]
5. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
[TBL] [Abstract][Full Text] [Related]
6. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
[TBL] [Abstract][Full Text] [Related]
7. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats.
Burcelin R; Printz RL; Kande J; Assan R; Granner DK; Girard J
Am J Physiol; 1993 Sep; 265(3 Pt 1):E392-401. PubMed ID: 8214048
[TBL] [Abstract][Full Text] [Related]
8. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Higuchi T; Miyakubo M; Ishikita T; Nakajima T; Endo K
Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.
Deron P; Vermeersch H; Mees G; Vangestel C; Pauwels P; Van de Wiele C
Histol Histopathol; 2011 Sep; 26(9):1165-72. PubMed ID: 21751148
[TBL] [Abstract][Full Text] [Related]
11. Development and regulation of glucose transporter and hexokinase expression in rat.
Postic C; Leturque A; Printz RL; Maulard P; Loizeau M; Granner DK; Girard J
Am J Physiol; 1994 Apr; 266(4 Pt 1):E548-59. PubMed ID: 8178975
[TBL] [Abstract][Full Text] [Related]
12. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
[TBL] [Abstract][Full Text] [Related]
13. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
[TBL] [Abstract][Full Text] [Related]
14. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).
El Sayed SM; Mahmoud AA; El Sawy SA; Abdelaal EA; Fouad AM; Yousif RS; Hashim MS; Hemdan SB; Kadry ZM; Abdelmoaty MA; Gabr AG; Omran FM; Nabo MM; Ahmed NS
Med Hypotheses; 2013 Nov; 81(5):866-70. PubMed ID: 24071366
[TBL] [Abstract][Full Text] [Related]
15. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.
Pedersen PL
J Bioenerg Biomembr; 2007 Jun; 39(3):211-22. PubMed ID: 17879147
[TBL] [Abstract][Full Text] [Related]
16. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
[TBL] [Abstract][Full Text] [Related]
17. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
[TBL] [Abstract][Full Text] [Related]
18. Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.
Tohma T; Okazumi S; Makino H; Cho A; Mochiduki R; Shuto K; Kudo H; Matsubara K; Gunji H; Ochiai T
Hepatogastroenterology; 2005; 52(62):486-90. PubMed ID: 15816463
[TBL] [Abstract][Full Text] [Related]
19. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Tong SY; Lee JM; Ki KD; Choi YJ; Seol HJ; Lee SK; Huh CY; Kim GY; Lim SJ
Int J Gynecol Cancer; 2012 May; 22(4):654-8. PubMed ID: 22398711
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK
Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
